dsm-firmenich raised its full-year like-for-like sales-growth outlook to around 5% in its 4 November trading update, replacing the previous 2–4% range. The group reported third-quarter continuing-operations sales of EUR 2.368 billion and like-for-like growth of 5%.

Adjusted EBITDA reached EUR 482 million. The quarterly adjusted margin was 20.4%, improving sequentially but slightly below the 20.5% reported a year earlier. Those two comparisons can coexist: improvement from the preceding quarter does not necessarily mean year-on-year expansion.

The figures cover continuing operations across the group’s portfolio. They should not be described as the growth rate of one food ingredient or of the Taste, Texture & Health business alone.

Keep corporate context separate from the quotation

For ingredient buyers, the update is a useful signal about the supplier’s overall trading environment and investment priorities. It does not determine the price, lead time or availability of a particular grade.

A technical enquiry can identify the application, required functionality and relevant business contact before seeking a commercial offer. This avoids treating a broad group announcement as a product specification.

Comparisons with other suppliers also need consistent definitions for currency effects, business perimeter and adjusted earnings. Retaining those labels helps commercial teams use the disclosure as background evidence while leaving actual purchasing decisions tied to the material and delivery commitment being proposed.

Orange juice and a waffle as a food-and-beverage illustration; not a dsm-firmenich fortified concept.

Further reading

Researched and written with AI assistance; references are listed for verification.

Explore food ingredients